Landercasper, Jeffrey
Borgert, Andrew J.
Fayanju, Oluwadamilola M.
Cody, Hiram III
Feldman, Sheldon
Greenberg, Caprice
Linebarger, Jared
Pockaj, Barbara
Wilke, Lee
Article History
Received: 9 April 2019
First Online: 24 July 2019
Change Date: 11 September 2019
Change Type: Correction
Change Details: The Disclosures in the original article are incomplete. Not included is the following information:
Disclosures
: Andrew Borgert and Dr. Landercasper receive funding from the Gundersen Medical Foundation; however, this is unrelated to the content of this manuscript. Dr. Fayanju is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under Award Number 1KL2TR002554 (PI: Svetkey) and by the Duke Cancer Institute through NIH grant P30CA014236 (PI: Kastan). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Dr. Cody, Dr. Feldman, Dr. Linebarger, and Dr. Pockaj have no disclosures. Dr. Greenberg is a consultant for Johnson and Johnson on their Global Education Council; this is unrelated to the content of this manuscript. Dr. Wilke is a founder and minority stock owner in Elucent Medical; this is unrelated to the content of this manuscript.